Literature DB >> 25824976

Locally Advanced Intrahepatic Cholangiocarcinoma: Complete Pathologic Response to Neoadjuvant Chemotherapy Followed by Left Hepatic Trisectionectomy and Caudate Lobectomy.

Thuy B Tran1, Chinmaya K Bal1, Kurt Schaberg2, Teri A Longacre2, Bhupinder S Chatrath3, George A Poultsides4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25824976     DOI： 10.1007/s10620-015-3640-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  19 in total

1.  Recurrence after surgical resection of intrahepatic cholangiocarcinoma.

Authors:  M Yamamoto; K Takasaki; T Otsubo; H Katsuragawa; S Katagiri
Journal:  J Hepatobiliary Pancreat Surg       Date:  2001

2.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.

Authors:  T Patel
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

Review 3.  Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.

Authors:  Anne M Horgan; Eitan Amir; Thomas Walter; Jennifer J Knox
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

4.  The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.

Authors:  Sae-Byeol Choi; Kyung-Sik Kim; Jin-Young Choi; Seung-Woo Park; Jin-Sub Choi; Woo-Jung Lee; Jae-Bock Chung
Journal:  Ann Surg Oncol       Date:  2009-07-22       Impact factor: 5.344

5.  A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer.

Authors:  Evan J Walker; Jeffry P Simko; Eric K Nakakura; Andrew H Ko
Journal:  J Gastrointest Oncol       Date:  2014-12

6.  Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.

Authors:  Mechteld C de Jong; Hari Nathan; Georgios C Sotiropoulos; Andreas Paul; Sorin Alexandrescu; Hugo Marques; Carlo Pulitano; Eduardo Barroso; Bryan M Clary; Luca Aldrighetti; Cristina R Ferrone; Andrew X Zhu; Todd W Bauer; Dustin M Walters; T Clark Gamblin; Kevin T Nguyen; Ryan Turley; Irinel Popescu; Catherine Hubert; Stephanie Meyer; Richard D Schulick; Michael A Choti; Jean-Francois Gigot; Gilles Mentha; Timothy M Pawlik
Journal:  J Clin Oncol       Date:  2011-07-05       Impact factor: 44.544

7.  Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials.

Authors:  J W Valle; J Furuse; M Jitlal; S Beare; N Mizuno; H Wasan; J Bridgewater; T Okusaka
Journal:  Ann Oncol       Date:  2013-12-18       Impact factor: 32.976

8.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

9.  Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma.

Authors:  Takahito Nakagawa; Toshiya Kamiyama; Nobuaki Kurauchi; Michiaki Matsushita; Kazuaki Nakanishi; Hirofumi Kamachi; Takeaki Kudo; Satoru Todo
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

10.  Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers.

Authors:  F Verderame; A Russo; R Di Leo; G Badalamenti; D Santangelo; G Cicero; M R Valerio; G Gulotta; G Tomasello; N Gebbia; F Fulfaro
Journal:  Ann Oncol       Date:  2006-06       Impact factor: 32.976
View more
  6 in total

Review 1.  Monitoring outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.

Authors:  Amir A Rahnemai-Azar; Pallavi Pandey; Ihab Kamel; Timothy M Pawlik
Journal:  Hepat Oncol       Date:  2017-01-20

Review 2.  Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma.

Authors:  Xing Chen; Jinpeng Du; Jiwei Huang; Yong Zeng; Kefei Yuan
Journal:  J Clin Transl Hepatol       Date:  2022-01-04

3.  Surgical management of biliary malignancy.

Authors:  T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica
Journal:  Curr Probl Surg       Date:  2020-06-30       Impact factor: 1.909

Review 4.  The Role of Surgical Resection and Liver Transplantation for the Treatment of Intrahepatic Cholangiocarcinoma.

Authors:  Guergana Panayotova; Jarot Guerra; James V Guarrera; Keri E Lunsford
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

Review 5.  Current role of trisectionectomy for hepatopancreatobiliary malignancies.

Authors:  Philipp Kron; Norihisa Kimura; Shahid Farid; J Peter A Lodge
Journal:  Ann Gastroenterol Surg       Date:  2019-10-22

6.  Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid.

Authors:  Zhiwei Wang; Yun Jin; Yinghao Guo; Zhenhua Tan; Xiaoxiao Zhang; Dan Ye; Yuanquan Yu; Shuyou Peng; Lei Zheng; Jiangtao Li
Journal:  Cancers (Basel)       Date:  2021-03-09       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.